Wildcat Capital Management, LLC
Long book
$106.2M
Q1 2026
Positions
2
Top-10 weight
100%
concentration
Last quarter
+106.0%
SPY +14.8%
Turnover
33%
of book per quarter
Strategy in plain words
auto-generated from filingsWildcat Capital Management, LLC is a diversified fundamental manager, specialised in industrials (93% of the long book), running a $106.2M US long book across 2 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: FRONTIER GROUP HOLDINGS INC, ALLOGENE THERAPEUTICS INC.
Over the last 9 quarters its long book ran on average 7.1pp per quarter ahead of the S&P 500, beating the index in 5 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-4.3%
Q2 2024
+11.8%
Q3 2024
+27.5%
Q4 2024
-33.7%
Q1 2025
-7.6%
Q2 2025
+21.6%
Q3 2025
+4.6%
Q4 2025
-22.0%
Q1 2026
+106.0%
Sector allocation
Industrials 93%
Healthcare 7%
Long book by quarter
What does Wildcat Capital own?
Q1 2026 13F13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 1, 2026 | 2 | $106.2M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 3, 2026 | 3 | $136.5M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 5 | $145.1M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Jul 18, 2025 | 6 | $168.3M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 2, 2025 | 8 | $187.4M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Jan 29, 2025 | 8 | $252.7M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 8, 2024 | 7 | $204.6M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 16 | $408.6M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 14, 2024 | 16 | $275.5M | canonical | SEC ↗ |